Natural Killer T Cells: Balancing the Regulation of Tumor Immunity - Masaki Terabe - Books - Springer - 9781461406129 - September 21, 2011
In case cover and title do not match, the title is correct

Natural Killer T Cells: Balancing the Regulation of Tumor Immunity 2012 edition

Price
€ 96.99

Ordered from remote warehouse

Expected delivery Dec 8 - 16
Christmas presents can be returned until 31 January
Add to your iMusic wish list

Brief Description: This book reviews what researchers have learned about NKT cells during the last two decades through functional studies in the context of tumor immunology, including clinical trials of NKT cell targeted therapy, which show promise for cancer treatment. Table of Contents: Preface.-Introduction: Mechanisms of NKT cell-mediated adjuvant activity and function of iPS-derived NKT cells.- Structure and Recognition of Antigens for Invariant NKT Cells.- Invariant NKT cell-based vaccine strategies.- Immune regulation of tumor immunity by NKT cells.- The Regulation of CD1d+ and CD1d- tumors by NKT Cells.- DC-based immunotherapy targeting NKT cells.- Therapeutic Approaches Utilising NKT Cells.- NKT Cells of Cancer Patients & How Models can Inform Therapeutic Plans.- Understanding the role of Natural Killer T (NKT) cells in hematologic malignancies: progress and challenges.- Clinical trials with -galactosylceramide (KRN7000) in advanced cancer.- Clinical trials of invariant Natural Killer T cell-based immunotherapy for cancer.- Index."Review Quotes: From the reviews: This book is essentially a collection of reviews that introduce the reader to the wonderful world of iNKT cells, and how their powerful adjuvant properties are being utilised by different researchers. this book is worth reading whether you are a new student in the NKT field and want to learn more or whether you are a clinician with an interest in tumour immunology. (Salah Mansour, Immunology News, November, 2012)"Jacket Description/Back: Natural killer T (NKT) cells are CD1d-restricted T cells that respond to lipid, not protein, antigens presented by CD1d, which is a non-classical MHC class I-like molecule. This relatively small but pivotal T cell population bridges the gap between innate and adaptive immunity by rapidly produce large amounts of many kinds of cytokines and by providing the T cell arm of the adaptive immune system a mechanism to detect lipid antigens. NKT cells also have both regulatory and effector functions and have been shown to play critical roles in the regulation of immune responses in many disease settings including cancer. Stimulating the protective functions of NKT cells while inhibiting the negative regulatory activity shows promise for the therapy of cancer and several approaches are in clinical trials. This book reviews what we have learned about NKT cells during last two decades through functional studies in the context of tumor immunology, including clinical trials of NKT cell targeted therapy. This knowledge should also be informative to understand the role of this underappreciated T cell population in many other fields outside of tumor immunology."Review Quotes: From the reviews: This book is essentially a collection of reviews that introduce the reader to the wonderful world of iNKT cells, and how their powerful adjuvant properties are being utilised by different researchers. this book is worth reading whether you are a new student in the NKT field and want to learn more or whether you are a clinician with an interest in tumour immunology. (Salah Mansour, Immunology News, November, 2012)


176 pages, 7 black & white illustrations, 16 colour illustrations

Media Books     Hardcover Book   (Book with hard spine and cover)
Released September 21, 2011
ISBN13 9781461406129
Publishers Springer
Pages 205
Dimensions 155 × 234 × 18 mm   ·   439 g
Language English  
Editor Berzofsky, J.
Editor Terabe, Masaki

Show all

More by Masaki Terabe

More from this series